Clinical and Translational Science Award (UM1 Clinical Trial Optional)
ID: 356316Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356316

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at enhancing clinical and translational research through collaborative partnerships. This initiative invites applications for hubs that will focus on improving the efficiency of clinical translation, addressing health disparities, and fostering innovative research methodologies, with a particular emphasis on community engagement and workforce development. Successful applicants, which may include higher education institutions and nonprofit organizations, are expected to outline strategic management and demonstrate strong leadership, with projects capped at seven years and a submission deadline of September 28, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the funding opportunity page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-272.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at accelerating clinical and translational research. The CTSA Program encourages applications for hubs that foster collaborative partnerships to streamline the development and dissemination of healthcare innovations across diverse communities. Key focus areas include enhancing research efficiency, addressing health disparities, and nurturing the capacity of clinical research professionals. The NOFO invites multiple types of applicants, notably higher education institutions and nonprofit organizations, with a project budget based on preceding NIH funding levels. Successful hub applications must outline strategic management, workforce development, community engagement, and innovative research methodologies with defined goals. Hubs are expected to not only conduct but also disseminate findings that contribute broadly to the translational science landscape. Applications are to be submitted by specific dates in 2025, with projects capped at seven years. This announcement reflects the NIH's commitment to improving healthcare outcomes through science, enhancing resource sharing and collaborative efforts within the CTSA consortium and beyond. Essential characteristics of successful hubs include strong leadership, institutional support, and a commitment to continuous quality improvement within the clinical research framework.
    Similar Opportunities
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development and demonstration of innovative resources and capabilities within Clinical and Translational Science Awards (CTSA) Program hubs, specifically targeting critical gaps and roadblocks in clinical research. Successful applicants, who must be active UM1 CTSA award recipients, will propose projects lasting up to five years with an annual budget cap of $500,000, emphasizing collaboration and innovation in health research. Interested parties should note that the application deadline is September 14, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Clinical and Translational Science Award (CTSA) Program for the Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research via innovative collaborations. This initiative invites applications that focus on developing and demonstrating innovative solutions to address common inefficiencies in the translational research process, ultimately facilitating quicker access to health interventions for diverse populations, particularly underserved communities. With an anticipated annual funding commitment of up to $6 million and a project period not exceeding five years, eligible applicants include public and state-controlled institutions of higher education, as well as active CTSA hub organizations that must submit joint applications involving at least three eligible entities. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by October 17, 2024.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Clinical and Translational Science Award (CTSA) Program, aimed at establishing hubs that will contribute to a national consortium focused on accelerating the delivery of treatments to patients through advancements in clinical and translational science. This initiative is designed to foster meaningful collaborations and responsive projects among eligible applicants, which include various organizations and institutions. The anticipated NOFO is expected to be published in Summer 2024, with applications due by January 2025, and the estimated award date is set for December 16, 2025. Interested parties should prepare for the upcoming application process as no cost-sharing or matching is required for this cooperative agreement funding opportunity.
    Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to re-issue the Notice of Funding Opportunity Announcement (PAR-22-167) for the Clinical and Translational Science Award (CTSA) Program, specifically the Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). This funding opportunity aims to foster meaningful collaborations and innovative projects in clinical and translational science, with no cost-sharing or matching requirements for eligible applicants, which include for-profit organizations. The estimated total program funding is $5 million, with an award ceiling of $650,000, and the NOFO is expected to be published in Fall 2024, with applications due in Winter 2025. Interested parties should prepare for the anticipated timeline, as the estimated project start date is December 1, 2025, and further details can be found on the CCIA webpage.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25), with a focus on educational activities that enhance research experiences in clinical and translational science. This initiative aims to support recipients of Clinical and Translational Science Awards (CTSA) by providing exposure to the scientific and operational principles of the translational process, covering areas such as pre-clinical research, clinical research, clinical implementation, and public health. The anticipated funding amount for this grant is up to $100,000, with the NOFO expected to be published in Summer 2024 and applications due by January 27, 2025. For further details, potential applicants are encouraged to prepare their proposals in advance of the expected award date on December 16, 2025.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the IDeA Clinical and Translational Research Network (CTR-N) Award, a federal grant aimed at enhancing clinical and translational research capacity in IDeA-eligible states and jurisdictions. This initiative seeks to develop infrastructure and human resources necessary for addressing health challenges, strengthen research competitiveness, and foster collaboration among participating organizations. The program emphasizes addressing health disparities and requires applicants to demonstrate collaborative capacity, submit an Overall Plan detailing healthcare concerns and research goals, and include a Plan for Enhancing Diverse Perspectives. The award ceiling is set at $1,300,000, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-241.html.
    IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) to enhance clinical and translational research capabilities in IDeA-eligible states. This funding opportunity aims to strengthen workforce development and improve infrastructure in health research organizations that typically have limited capacities for such research, with a focus on building research capacity and fostering collaboration within the community. Each organization can submit one application with a budget not exceeding $1.5 million over a maximum project period of five years, and successful applicants must address various cores including Administrative, Professional Development, Community Engagement, Research Design/Compliance, and Health Research, while also emphasizing diversity and inclusion in research. Interested applicants can find more information and submit their applications through the NIH ASSIST system or Grants.gov, with the application deadline set for October 9, 2025.
    Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a limited competition opportunity for the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to enhance predoctoral research training for individuals pursuing a PhD or equivalent health professional degree, focusing on developing a diverse pool of clinical and translational scientists equipped to advance health diagnostics, therapeutics, and interventions. The Notice of Funding Opportunity (NOFO) is expected to be published in Summer 2024, with applications due in January 2025, and the estimated award date is set for December 16, 2025. Interested institutions should prepare for collaboration and project development in advance of the application period.
    Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Intent for a limited competition grant opportunity titled the Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to enhance postdoctoral research training for individuals holding various doctoral degrees, ensuring a diverse pool of clinical and translational scientists who can advance health-related diagnostics, therapeutics, and interventions. The anticipated Notice of Funding Opportunity (NOFO) is expected to be published in Summer 2024, with applications due by January 2025, and awards projected to be made by December 2025. Interested institutions should prepare to develop collaborative projects in response to this opportunity.